D. Beard

发表

Intracellular inorganic phosphate and ATP levels in human blood erythrocytes, leucocytes and platelets in normal subjects and in diseases associated with altered phosphate metabolism.

J. Kanis, R. Russell, A. Challa, 1982, Advances in experimental medicine and biology.

The Diagnostic and Aetiological Significance of Certain Ultrastructural Features of the Osteoclasts in Paget's Disease of Bone

J. Kanis, R. Russell, D. L. Douglas, 1981 .

Drug treatment of primary hyperparathyroidism: use of clodronate disodium.

J. Kanis, R. Russell, D. L. Douglas, 1983, British medical journal.

Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.

J. Kanis, T. Duckworth, R. Russell, 1980, Arthritis and rheumatism.

Treatment of malignant hypercalcaemia with clodronate.

J. Kanis, R. Russell, F. Neal, 1985, British Journal of Cancer.

Treatment ofmalignant hypercalcaemia withclodronate

J. Kanis, R. Russell, F. Neal, 1985 .

The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma

F. Preston, D. L. Douglas, E. Cameron, 1983, British journal of haematology.

One-Pot FriedländerQuinoline Synthesis: Scope and Limitations

D. Werner, A. Crew, Kam W. Siu, 2010 .

Inhalation anaesthetics and their interaction in vitro with glutamate dehydrogenase and other enzymes.

D. Beard, G. Hulands, A. Brammall, 1974, British journal of anaesthesia.

Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.

J. Kanis, S. Harris, R. Russell, 1985, Bone.

Biochemical markers of bone turnover in Paget's disease.

J. Kanis, A. Milford-Ward, J. Poser, 1981, Metabolic bone disease & related research.

Paget's disease: improvement of spinal cord dysfunction with diphosphonates and calcitonin.

J. Kanis, T. Duckworth, R. Russell, 1981, Metabolic bone disease & related research.

Potential Clinical use of Diphosphonates Against Bone Metastases and Hypercalcaemia of Malignancy

J. Kanis, F. Preston, R. Russell, 1980 .

ABNORMAL VITAMIN D METABOLISM IN PAGET'S DISEASE OF BONE

S. Johnson, D. L. Douglas, D. Beard, 1985, Clinical endocrinology.

The physical dependence liabilities of oxybutynin and morphine in rats.

D. Beard, D. Algate, 1985, Arzneimittel-Forschung.

Oxyhaemoglobin dissociation curves in vitro with and without the anaesthetics halothane and cyclopropane.

R. Millar, D. Beard, G. Hulands, 1971, British journal of anaesthesia.

Study of the effects of oral administration of CDP-choline on EEG changes and lethality induced by epidural compression in the anaesthetised cat.

J. Davies, D. Beard, J. Ortiz, 1983, Arzneimittel-Forschung.

General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals.

S. Laufer, J. Augustin, D. Beard, 1995, Arzneimittel-Forschung.

Drug Treatment of Primary Hyperparathyroidism: Use of Clodronate Disodium

J. Kanis, D. L. Douglas, E. Cameron, 1983 .

Preganglionic sympathetic activity and baroreceptor responses during hypothermia.

R. Millar, S. U. Kaul, D. Beard, 1973, British journal of anaesthesia.